BMSSC
IDXX icon

B. Metzler seel. Sohn & Co’s Idexx Laboratories IDXX Stock Holding History

B. Metzler seel. Sohn & Co’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.93M Sell
13,155
-3,087
-19% -$1.73M 0.06% 175
2026
Q1 		$9.13M Sell
16,242
-134
-0.8% -$85.9K 0.08% 132
2025
Q4 		$11.1M Sell
16,376
-571
-3% -$389K 0.1% 116
2025
Q3 		$10.8M Sell
16,947
-4,388
-21% -$2.66M 0.1% 109
2025
Q2 		$11.4M Buy
21,335
+1,017
+5% +$486K 0.11% 97
2025
Q1 		$8.53M Buy
20,318
+5,761
+40% +$2.5M 0.09% 115
2024
Q4 		$6.02M Buy
14,557
+5,322
+58% +$2.33M 0.06% 150
2024
Q3 		$4.67M Buy
9,235
+215
+2% +$104K 0.05% 205
2024
Q2 		$4.39M Buy
9,020
+122
+1% +$61.2K 0.04% 209
2024
Q1 		$4.8M Sell
8,898
-10,643
-54% -$5.82M 0.05% 195
2023
Q4 		$10.8M Buy
19,541
+2,796
+17% +$1.31M 0.14% 90
2023
Q3 		$7.32M Buy
16,745
+1,637
+11% +$816K 0.11% 112
2023
Q2 		$7.59M Buy
15,108
+10,428
+223% +$5M 0.1% 136
2023
Q1 		$2.34M Sell
4,680
-862
-16% -$413K 0.04% 267
2022
Q4 		$2.26M Sell
5,542
-1,396
-20% -$542K 0.04% 261
2022
Q3 		$2.26M Sell
6,938
-3,099
-31% -$1.14M 0.04% 259
2022
Q2 		$3.52M Buy
10,037
+1,239
+14% +$505K 0.06% 204
2022
Q1 		$4.81M Buy
8,798
+468
+6% +$246K 0.06% 190
2021
Q4 		$5.51M Buy
8,330
+3,030
+57% +$1.9M 0.07% 175
2021
Q3 		$3.3M Sell
5,300
-97
-2% -$65.2K 0.05% 229
2021
Q2 		$3.41M Buy
5,397
+153
+3% +$84.5K 0.05% 213
2021
Q1 		$2.57M Buy
5,244
+89
+2% +$44.6K 0.04% 249
2020
Q4 		$2.67M Buy
+5,155
New +$2.31M 0.05% 214

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

B. Metzler seel. Sohn & Co's IDXX Position: Q2 2026 in Review

B. Metzler seel. Sohn & Co reduced its Idexx Laboratories (IDXX) stake by 19% in Q2 2026, selling an estimated $1.73M and leaving 13,155 shares worth $6.93M. The position accounts for 0.06% of the portfolio, ranked #175.

B. Metzler seel. Sohn & Co first reported a position in IDXX in Q4 2020 and has held it in 23 quarters since. The position peaked at $11.4M in Q2 2025. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • B. Metzler seel. Sohn & Co held 13,155 shares of Idexx Laboratories worth $6.93M as of Q2 2026.
  • B. Metzler seel. Sohn & Co sold 3,087 Idexx Laboratories shares in Q2 2026, an estimated $1.73M.
  • Idexx Laboratories made up 0.06% of B. Metzler seel. Sohn & Co's portfolio in Q2 2026, its #175 holding.
  • B. Metzler seel. Sohn & Co first reported a position in Idexx Laboratories in Q4 2020 and has held it in 23 quarters since.
  • B. Metzler seel. Sohn & Co's Idexx Laboratories position peaked at $11.4M in Q2 2025.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on B. Metzler seel. Sohn & Co's 13F filing for Q2 2026, filed 11 Aug 2026.